rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
1997-2-4
|
pubmed:abstractText |
Cytokines are implicated in the pathogenesis of the "whole-body inflammatory response" that may complicate the period after cardiopulmonary bypass (CPB). Low-Dose aprotinin in the pump during CPB has been shown to improve postoperative hemostasis and platelet preservation. We tested the hypothesis that low-dose aprotinin influences the inflammatory reaction (in terms of cytokine release) after CPB.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0003-4975
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
63
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
68-73
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8993243-Aged,
pubmed-meshheading:8993243-Aprotinin,
pubmed-meshheading:8993243-Blood Loss, Surgical,
pubmed-meshheading:8993243-Cardiopulmonary Bypass,
pubmed-meshheading:8993243-Coronary Artery Bypass,
pubmed-meshheading:8993243-Cytokines,
pubmed-meshheading:8993243-Female,
pubmed-meshheading:8993243-Fibrinolysis,
pubmed-meshheading:8993243-Hemostasis,
pubmed-meshheading:8993243-Hemostatics,
pubmed-meshheading:8993243-Humans,
pubmed-meshheading:8993243-Male,
pubmed-meshheading:8993243-Middle Aged,
pubmed-meshheading:8993243-Prospective Studies
|
pubmed:year |
1997
|
pubmed:articleTitle |
"Low-dose" aprotinin modifies hemostasis but not proinflammatory cytokine release.
|
pubmed:affiliation |
Cardiothoracic Department, Killingbeck Hospital, Leeds, United Kingdom.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial
|